Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The conf call was last night after hours.
We are amending and restating our Articles of Incorporation in their entirety to make the following changes:
Increase in Authorized Common and Preferred Stock. We are increasing our authorized common stock from 300,000,000 to 5,000,000,000 and our authorized preferred stock from 10,000,000 to 50,000,000.
Reduction in Par Value. We are reducing the par value per share of our common and preferred stock from $0.001 to $0.00001 per share.
Anti-takeover provisions. The Company’s Amended and Restated Articles of Incorporation provide that the Board of Directors may issue up to 50,000,000 shares of “blank check” Preferred Stock and fix the rights, preferences, privileges, qualifications, limitations, and restrictions of any Preferred Stock issued by the Company, including the number of shares constituting any series or the designation of such series. The existence of unissued Preferred Stock may enable the Board of Directors, without further action by the stockholders, to issue such stock to persons friendly to current management or to issue such stock with terms that could render more difficult or discourage an attempt to obtain control of the Company, thereby protecting the continuity of the Company’s management.
These changes to our Articles of Incorporation will enable the Company’s board of directors, without further authorization from shareholders, to issue up to 5,000,000,000 shares of common stock and up to 50,000,000 shares of preferred stock having such rights, privileges, and preferences as determined by the board of directors, for consideration deemed adequate in exchange for such shares. We have attached a copy of the Restatement to this Information Statement.
Thanks for the update. I was not able to attend the conf call.
Elevator music?
They will have a recording available at 7:30PM . I am sure people will also post here.
A replay of the call will be available beginning August 13, 2015, at 7:30 p.m. EDT until August 20, 2015, at 11:59 p.m. EDT by dialing 1-858-384-5517 and entering pin number 115869
I am out of this POS
I might get back in @ 5. I spent the day reading forums about this company. They are famous for going dark over the years. Then bam, they release info and it pops.
It happens all the time with domain names. There is nothing weird about it.
Why was August such and important month? I have been watching this forum and for over a month people have been saying "no news by August this hits trips" . It only started hitting the trips in August. Why was August so important?
They have a history of Notification of Late Filing so we shall see. Most likely will be a joke like all the other times they filed.
Their DNS has mismatched nameservers. That is why their MX records are not reporting correctly. Looks liek thye host their email with gooogle apps >> http://www.intodns.com/rushforstocks.com
Unilife Corp was downgraded by Zacks
Unilife Corp (NASDAQ:UNIS) was downgraded by Zacks from a “hold” rating to a “sell” rating in a report released on Monday, MarketBeat.com reports.
According to Zacks, “Unilife Corporation is a medical device company based in U.S., focused on the design, development, manufacture and supply of a proprietary range of retractable syringes. The primary target customers for the Company’s products include pharmaceutical manufacturers, suppliers of medical equipment to healthcare facilities and patients who self-administer prescription medication. These patent-protected syringes incorporate automatic and fully-integrated safety features which are designed to protect those at risk of needlestick injuries and unsafe injection practices. Unilife’s main product is the Unifill ready-to-fill syringe, which is designed to be supplied to pharmaceutical manufacturers in a form that is ready for filling with injectable drugs and vaccines. Unilife Corporation has FDA-registered medical device manufacturing facilities in Pennsylvania. “
Shares of Unilife Corp (NASDAQ:UNIS) traded down 0.72% on Monday, reaching $1.38. The company had a trading volume of 930,962 shares. The firm’s market capitalization is $166.49 million. The stock’s 50 day moving average is $1.92 and its 200 day moving average is $3.11. Unilife Corp has a 52 week low of $1.15 and a 52 week high of $4.90.
Unilife Corp (NASDAQ:UNIS) last announced its quarterly earnings data on Monday, May 11th. The company reported ($0.14) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.12) by $0.02. The business had revenue of $2.90 million for the quarter, compared to analyst estimates of $8.75 million. On average, equities analysts anticipate that Unilife Corp will post ($0.72) EPS for the current year.
A number of other equities analysts have also commented on UNIS. Piper Jaffray reissued an “overweight” rating and set a $12.00 price objective (up from $10.00) on shares of Unilife Corp in a report on Thursday, July 30th. Griffin Securities lowered shares of Unilife Corp to a “hold” rating in a report on Saturday, August 1st. Finally, Jefferies Group downgraded shares of Unilife Corp from a “buy” rating to a “hold” rating and lowered their price objective for the stock from $8.00 to $1.50 in a research note on Thursday. One research analyst has rated the stock with a sell rating, two have given a hold rating and two have given a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus target price of $6.17.
In related news, insider Dennis Pyers sold 17,349 shares of the company’s stock in a transaction dated Friday, May 15th. The shares were sold at an average price of $3.08, for a total transaction of $53,434.92. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
Unilife Corporation, is a drug delivery company. The Company has product platforms, including pre-filled syringes, drug reconstitution delivery systems, auto-injectors, wearable injectors, ocular delivery systems and other novel injectable drug delivery systems. The Company’s product platform includes: Pre-filled Syringes, Wearable Injectors, Auto-Injectors, Drug Reconstitution Delivery Systems, and Ocular Delivery Systems. Pre-filled Syringes, offers a single-chamber pre-filled syringe, Unifill. Wearable Injectors, offers pre-filled and disposable devices, ReadyToGo. Auto-Injectors, offers disposable and reusable auto-injectors, LISA and RITA. Drug Reconstitution Delivery Systems, offers dual-chamber pre-filled syringes, EZMix. Ocular Delivery Systems, offers localized and targeted delivery of ophthalmic therapies.
To get a free copy of the research report on Unilife Corp (UNIS), click here. For more information about research offerings from Zacks Investment Research, visit Zacks.com
If WANG is in.. I am in!
From reviewing the chart, it seems early May is when they need to pay their salaries. There always seems to be action that time of the year on the charts. So for who is holding.....April 2016 will be good for you. But right now the price is to high to buy for next April.
Shares of Unilife Corporation (NASDAQ:UNIS) Drops by -21.02%
Unilife Corporation (NASDAQ:UNIS) has lost 21.02% during the past week and dropped 28.35% in the last 4 weeks. The shares are however, negative as compared to the S&P 500 for the past week with a loss of 20.02%. Unilife Corporation (NASDAQ:UNIS) has underperformed the index by 28.38% in the last 4 weeks. Investors should watch out for further signals and trade with caution.
Unilife Corporation has dropped 57.49% during the last 3-month period . Year-to-Date the stock performance stands at -58.51%. The company shares have dropped 40.09% in the past 52 Weeks. On January 27, 2015 The shares registered one year high of $4.9 and one year low was seen on August 6, 2015 at $1.15. The 50-day moving average is $1.95 and the 200 day moving average is recorded at $3.15. S&P 500 has rallied 7.26% during the last 52-weeks.
The company has received recommendation from many analysts. 4 analysts have rated the company as a strong buy. 2 analysts have suggested buy for the company.
On a different note, The Company has disclosed insider buying and selling activities to the Securities Exchange, The officer (See Remarks), of Unilife Corp, Pyers Dennis had unloaded 17,349 shares at $3.08 per share in a transaction on May 14, 2015. The total value of transaction was $53,435. The Insider information was revealed by the Securities and Exchange Commission in a Form 4 filing.
Shares of Unilife Corporation (NASDAQ:UNIS) ended Friday session in red amid volatile trading. The shares closed down 0.06 points or 4.14% at $1.39 with 1,442,652 shares getting traded. Post opening the session at $1.39, the shares hit an intraday low of $1.37 and an intraday high of $1.45 and the price vacillated in this range throughout the day. The company has a market cap of $182 million and the number of outstanding shares have been calculated to be 131,215,000 shares. The 52-week high of Unilife Corporation (NASDAQ:UNIS) is $4.9 and the 52-week low is $1.15.
Unilife Corporation (Unilife) is a developer, manufacturer and supplier of injectable drugs delivery systems. The Company manufactures and supplies its devices to pharmaceutical companies in a format where they can be filled and packaged with an injectable therapy prior to its shipment to the end-user. The Companys technology platforms cover six device categories: Prefilled Syringes, Drug Reconstitution Delivery Systems, Auto-Injectors, Wearable Injectors, Ocular Delivery Systems and Delivery Systems.
This is sad to see. Months ago I wanted it to hit the trips so I could say "told ya so". But since then I have enjoyed the community here. You guys and gals are truly an amazing group of people.
Good luck to all. Best of luck trading.
Great Day! Have a great weekend!
You are the only one who stuck up for them the whole time. Crazy. How did they know who you are?
I did know what that meant. I just googled that at my work that logs everything lmao.
They gave huge fluffed PR's already. I do not know what you expect them to say. There is not much more to say in a PR. If the PR's about the symbol change, convertibles and reverse merger are not enough, what more do you expect?
Analyst Rating Update on Unilife Corporation
Research firm Zacks has rated Unilife Corporation (NASDAQ:UNIS) and has ranked it at 3, indicating that for the short term the shares are a hold. 5 Wall Street analysts have given the company an average rating of 1.4. The shares have received a hold rating based on the suggestion from 1 analysts in latest recommendations. Strong buy was given by 4 Wall Street Analysts.
Unilife Corporation (NASDAQ:UNIS) stock has received a short term price target of $ 8.56 from 4 Analyst. The share price can be expected to fluctuate from the mean short term target, can be seen from the standard deviation reading of $2.44. The higher estimate of target price is $12 , while the lower price target estimate is $6
Company has received recommendation from many analysts. In a research note released to the investors, Griffin Securities downgrades its rating on Unilife Corporation (NASDAQ:UNIS).The analysts at the brokerage house have a current rating of Neutral on the shares. The rating by the firm was issued on July 31, 2015.
Shares of Unilife Corporation (NASDAQ:UNIS) ended Thursday session in red amid volatile trading. The shares closed down 0.11 points or 7.05% at $1.45 with 3,524,429 shares getting traded. Post opening the session at $1.5, the shares hit an intraday low of $1.15 and an intraday high of $1.53 and the price vacillated in this range throughout the day. The company has a market cap of $190 million and the number of outstanding shares have been calculated to be 131,215,000 shares. The 52-week high of Unilife Corporation (NASDAQ:UNIS) is $4.9 and the 52-week low is $1.53.
The company shares have dropped 32.47% in the past 52 Weeks. On January 27, 2015 The shares registered one year high of $4.9 and one year low was seen on August 5, 2015 at $1.53. The 50-day moving average is $2.01 and the 200 day moving average is recorded at $3.18. S&P 500 has rallied 9.96% during the last 52-weeks.
Unilife Corporation (Unilife) is a developer, manufacturer and supplier of injectable drugs delivery systems. The Company manufactures and supplies its devices to pharmaceutical companies in a format where they can be filled and packaged with an injectable therapy prior to its shipment to the end-user. The Companys technology platforms cover six device categories: Prefilled Syringes, Drug Reconstitution Delivery Systems, Auto-Injectors, Wearable Injectors, Ocular Delivery Systems and Delivery Systems.
They had the chance for over a week to sell. I even posted here when the stock was in the mid 2's to sell. I just got made fun of. You could of sold then and bought 2x as much now.
I will be honest, this was the first penny I ever made money off of. That is why I always come back here.
The conf call was a total failure. I used to drive to work thinking how much I will make off of this deal. I truly believed they had a deal with Verizon. As we all know I was let down. I held it for days after the failed conf call. People kept holding their shares thinking the conf call would happen, which made me $$$ .
Pennypuptech you were here for the whole deal. The TLFX forum was blowing up with investors, breakout boards... you name it, it was happening here. We had a complete insight to the company threw investors.
Now we are now facing trips. The email response you have from the CEO makes her sound weak and incompetent. Her feelings were hurt etc.
HOW ABOUT THE TRADERS WHO INVESTED IN THIS COMPANY! WHEN CAN THEY FEEL SAD THEY INVESTED INTO THIS MESS? THE COMPANY OWES US THIS!
At $1.17 I was almost out today. Scary ride but the rebound was awesome.
How many shares of INMG do you think Warren Buffett owns?
True, telling someone to hang on to a penny stock long term is great advice.
INMG Millionaire Christmas Party? Who is attending?
Get your tickets now. Only 90 million left at .0003.
Location of INMG Millionaire Christmas will be determined later. We will make sure it is near a port and private airport so you can bring your toys.
These guys are clowns. Most of us knew they were playing the same scam they did before. It was almost as if they pulled out their playbook and just changed symbols and created new ones. We bought in at 2 and waited. The news came out and it was going run big time......then before it even had a chance to run, they started heavy dilution. Why would they not let it run first?
Lucky most of us that were playing only lost the cost of the trade at our broker.
Now it is a bad a bad story. 10K on the bid for 2's ( $2 ) . Over 90 million on the ask for 3's. My guess is, most have more then $2 invested, so your order to sell at 2 would not even fill right now.
I am not sure what "meaty PR" you guys are waiting for. You got all the fluff PR's already. Unless they come out with some serious great financials, this is going to 0001 fast. From listening to the interview, he only talks about getting more financing, so I would not wait on financials.
Stats at around 3PM today:
Bid 0.0002 x 10,000
Ask 0.0003 x 90,424,955
Vol 21,283,550
Before $6 Paint:
Bid 0.0002 x 10,000
Ask 0.0003 x 90,424,955
Vol 21,283,550
After Paint:
Bid 0.0002 x 10,000
Ask 0.0003 x 90,404,955
Vol 21,303,550
$6 move, truly pathetic.
I am waiting for it also
Please let us know where you found it while you were digging around so we do not look there for future advice.
Jefferies Downgrades Unilife to Hold
Brokerage firm Jefferies Downgrades its rating on Unilife(NASDAQ:UNIS). The shares have been rated Hold. Previously, the analysts had a Buy rating on the counter. The rating by Jefferies was issued on Aug 6, 2015.
Unilife Corporation (UNIS): 5 Brokerage firm Analysts have agreed with the mean estimate for the short term price target of $9.55 in Unilife Corporation (UNIS). However, the stock price could fluctuate by $ 3.58 from the estimate as it is suggested by the standard deviation reading. The higher estimate has been put at $16 price target with the lower price estimate is calculated at $6 Unilife Corporation has lost 9.84% in the last five trading days and dropped 19.51% in the last 4 weeks. Unilife Corporation has dropped 49.7% during the last 3-month period . Year-to-Date the stock performance stands at -50.75%.
Currently the company Insiders own 1.2% of Unilife Corporation Company shares. In the past six months, there is a change of -2.14% in the total insider ownership. Institutional Investors own 40.3% of Company shares. During last 3 month period, 0.43% of total institutional ownership has changed in the company shares. On a different note, The Company has disclosed insider buying and selling activities to the Securities Exchange, The officer (See Remarks), of Unilife Corp, Pyers Dennis had unloaded 17,349 shares at $3.08 per share in a transaction on May 14, 2015. The total value of transaction was $53,435. The Insider information was revealed by the Securities and Exchange Commission in a Form 4 filing.
Unilife Corporation (UNIS) : On Tuesday heightened volatility was witnessed in Unilife Corporation (UNIS) which led to swings in the share price. The shares opened for trading at $1.61 and hit $1.6699 on the upside , eventually ending the session at $1.65, with a gain of 2.48% or 0.04 points. The heightened volatility saw the trading volume jump to 1,335,929 shares. The 52-week high of the share price is $4.9 and the company has a market cap of $217 million. The 52-week low of the share price is at $1.59 .
Unilife Corporation (Unilife) is a developer, manufacturer and supplier of injectable drugs delivery systems. The Company manufactures and supplies its devices to pharmaceutical companies in a format where they can be filled and packaged with an injectable therapy prior to its shipment to the end-user. The Company’s technology platforms cover six device categories: Prefilled Syringes, Drug Reconstitution Delivery Systems, Auto-Injectors, Wearable Injectors, Ocular Delivery Systems and Delivery Systems.
Every CEO in sub penny land is a nice person. Read around the forums and hear the stories of the "nice ceo's". All I read in forums is " I know they did dilution, convertible notes and a big Reverse Split but the CEO is very nice and promises to never do it again. This is every penny stock board.
Her feelings got hurt? She needs to put on her adult pants and run a business. She lied to everyone about the conf call and never rescheduled it. She is cold, I do not see feelings from a CEO that does this to a shareholders.
Was it in a newsletter or Twitter from Big Money Mike?
Long term they only lose unless this is on a corporate level who benefits huge from it. If it was just today I could understand but daily for 2 weeks? I think I am reporting this as fraud. I am pretty sure it is the same broker account doing this daily.
This has been happening for 2 weeks. I wanted to see how many they are buying to paint it but missed it. Someone is paying a lot in broker fees to keep this going daily.
What award did the CEO win? The stock should balance out once the toxic financing is finished.
We bash so we can get cheapies. As soon as this is .0001 with zero bid, we swoop in lol
They do every day.
They do everyday before just before the market closes.
The people with the $ sign next to their name do.